Through the analysis of transcriptomic and genomic profiling data, we found that PLK3 expression level was highly correlated to the malignancy of gliomas, and we validated that PLK3 could promote the GBM process in vitro and in vivo experiments. The gene discussed is PLK3; the disease is glioma.